Torrent Pharmaceuticals Limited
TORNTPHARM · NSE— · —
₹4,429.8
Closing price — 19 Jun 2026
Market cap ₹1,49,723 Cr · EPS ₹64.01
Loading financial data for Torrent Pharmaceuticals Limited…
Valuation
Blended fair value using DCF and peer comparison methods.
Peer comparison
How this company stacks up against sector peers on valuation and quality metrics.
Branded generics & specialty pharma · 8 peers · sector medians shown
Better than medianWorse than median
| Company | Mkt Cap | P/E | P/B | EV/EBITDA | ROE | Net Margin | Rev CAGR 3y |
|---|---|---|---|---|---|---|---|
Torrent Pharmaceuticals Limited TORNTPHARM · you | ₹1.5 L Cr | 69.2× | 17.9× | 36.1× | 25.8% | 15.5% | 13.3% |
| Sector median | — | 28.5× | 3.7× | 24.2× | 11.5% | 13.6% | 10.8% |
| Sun Pharmaceutical SUNPHARMA | ₹4.3 L Cr | 38.5× | 5.1× | 28.5× | 13.7% | 19.6% | 10.0% |
| Zydus Lifesciences ZYDUSLIFE | ₹1.1 L Cr | 24.6× | 4.1× | 20.3× | 16.7% | 16.7% | 16.3% |
| Cipla CIPLA | ₹1.1 L Cr | 29.1× | 3.3× | — | 11.3% | 13.8% | 7.4% |
| Dr Reddy's Laboratories DRREDDY | ₹1.1 L Cr | 25.2× | 2.8× | — | 11.1% | 12.5% | 11.0% |
| Mankind Pharma MANKIND | ₹98,725 Cr | 51.7× | 6.0× | 29.1× | 11.7% | 13.4% | 17.7% |
| Aurobindo Pharma AUROPHARMA | ₹83,993 Cr | 24.1× | 2.2× | 12.5× | 9.2% | 10.4% | 10.6% |
| Biocon BIOCON | ₹67,470 Cr | 145.1× | 1.9× | 25.6× | 1.1% | 2.3% | 14.8% |
| Alkem Laboratories ALKEM | ₹63,998 Cr | 27.8× | 4.6× | 22.8× | 16.7% | 15.6% | 8.2% |
Peer comparison verdict
Torrent trades at a premium to peers (P/E 69.2× vs median 28.5×), but its higher ROE of 25.8% (sector 11.5%) justifies much of that premium — quality rarely comes cheap.
Business quality
Key profitability, efficiency, and solvency metrics.
Financial health
Piotroski F-Score, Altman Z-Score, and key solvency ratios.
Full financial data
Charts and annual statements for income, balance sheet and cash flow.
Income trend
Revenue, profit and margin trends over time.
Income statement data is loading…
Cash flow
Where cash comes from and where it goes.
Balance sheet
Assets show what the company owns. Liabilities show what it owes. Equity is what's left for shareholders.
Balance sheet data is loading… if this persists, financial data may be temporarily unavailable.
Numbers are illustrative — order-of-magnitude correct. For precise figures, refer to the company's annual report on BSE/NSE.